Candid Health Secures $120 Million in Latest Series D Funding Round

Candid Health secured $120 million in its latest Series D, adding another data point to the Healthcare & Life Sciences funding market.

Candid Health Raises $120 million in Funding

Candid Health Raises $120 Million Series D To Expand Autonomous Healthcare Revenue Cycle Platform. Candid Health raises $120 million to take on America’s $280 billion medical billing mess. Candid Health Raises $120 Million Series D To Expand Autonomous Healthcare Revenue Cycle Platform Candid Health Raises $120M in Series D Funding Six months after raising $29M, Candid Health nabs another $52.5M to ease medical billing. Candid Health Raises $120 Million Series D To Expand.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Candid Health operates in Healthcare & Life Sciences. Candid Health's financing adds to recent private-market activity.

Strategic Use of Funds

Expand Autonomous Healthcare Revenue Cycle Platform.

Looking Ahead

Candid Health Raises $120 Million Series D To Expand Autonomous Healthcare Revenue Cycle Platform

Source reference: original announcement/article.